MARKET

ICAD

ICAD

Icad Inc
NASDAQ
1.530
+0.160
+11.68%
Opening 09:34 11/28 EST
OPEN
1.490
PREV CLOSE
1.370
HIGH
1.600
LOW
1.420
VOLUME
67.25K
TURNOVER
0
52 WEEK HIGH
3.970
52 WEEK LOW
1.050
MARKET CAP
40.32M
P/E (TTM)
-3.8724
1D
5D
1M
3M
1Y
5Y
12 Health Care Stocks Moving In Tuesday's Pre-Market Session
Gainers avidity biosciences (nasdaq:rna) shares rose 38.1% to $8.51 during tuesday's pre-market session. Heart test laboratories shares moved upwards by 22.98%. Icad shares increased by 17.51% and senestech stock decreased by 38.3%. Tharimmune stock fell 69.5% during the session.
Benzinga · 7h ago
iCAD's ProFound AI Can Predict 1-2 Year Risk For Breast Cancer And Reveal Insights For Heart Disease
New research presented at radiological society of north america annual meeting confirms ability of profound breast health suite to predict a woman's one to two-year risk for breast cancer. Icad unveils new solution that assesses calcium deposits in the breast arteries as a proxy for hidden cardiovascular disease. Researchers will present their findings at the radiological society of. North america's annual meeting in chicago.
Benzinga · 1d ago
Weekly Report: what happened at ICAD last week (1120-1124)?
Weekly Report · 1d ago
Discover Future Growth Stocks: 3 Penny Stocks Poised for Massive Returns
NASDAQ · 3d ago
Weekly Report: what happened at ICAD last week (1113-1117)?
Weekly Report · 11/20 12:19
Icad Inc: Quarterly report
Press release · 11/14 19:12
Craig-Hallum Reaffirms Their Buy Rating on iCAD (ICAD)
TipRanks · 11/14 14:07
ICAD’s Shift to Subscription-Based Model and Strong Financial Health Prompts Buy Rating: An Analysis by BTIG’s Marie Thibault
TipRanks · 11/14 03:25
More
About ICAD
iCAD, Inc. is a global medical technology company, which provides cancer detection and therapy solutions. The Company is focused on providing breast cancer detection solutions built on artificial intelligence (AI) that empowers radiologists to find cancers. Its solutions include advanced image analysis and workflow solutions that enable healthcare professionals to better serve patients by identifying pathologies and pinpointing the most prevalent cancers earlier, and a range of high-performance, AI and computer-aided detection (CAD) systems and workflow solutions for 2D and 3D mammography, magnetic resonance imaging and computed tomography (CT). The Company’s Breast AI Suite offers a triple threat of clinically proven cancer detection, density assessment, and risk evaluation solutions, designed to accelerate discovery and improve outcomes. It also offers ProFound AI, a digital breast tomosynthesis (DBT) cancer detection and workflow solution.

Webull offers iCAD Inc stock information, including NASDAQ: ICAD real-time market quotes, financial reports, professional analyst ratings, in-depth charts, corporate actions, ICAD stock news, and many more online research tools to help you make informed decisions. Trade stocks for 0 commission and 0 contract fees on the web version for easy and convenient access, or download the Webull app and trade on the go.

You can practice and explore trading ICAD stock methods without spending real money on the virtual paper trading platform.